NRXS
NeurAxis, Inc.
NASDAQ · USHealthcareBiotechnology
$6.86+1.63%
Price as of Jul 20, 2026
NRXS valuation
NeurAxis, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.78x
- Price / sales
- 19.84x
- Price / cash flow
- -14.02x
Enterprise value
- Enterprise value
- $78.2M
- EV / sales
- 18.27x
- EV / EBITDA
- -10.99x
- EV / EBIT
- -10.75x
- Market cap
- $85.0M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.